Martin White1, Robyn Burton1, Shane Darke2, Brian Eastwood1,3, Jon Knight1, Tim Millar4, Virginia Musto1, John Marsden1,3. 1. Alcohol, Drugs and Tobacco Division, Health and Wellbeing Directorate, Public Health England, London, UK. 2. National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia. 3. Addictions Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. 4. Centre for Mental Health and Risk, Institute of Brain, Behaviour and Mental Health, The University of Manchester, Manchester, UK.
Abstract
AIM: A counterfactual model was used to estimate the number of fatal opioid-related poisonings prevented by public treatment services for opioid use disorder (OUD) in England between April 2008 and March 2011. METHODS: Patient OUD treatment episode data recorded by the English National Drug Treatment Monitoring System were linked to data on opioid deaths recorded by the Office for National Statistics. The source population was the official estimate of non-medical opioid users (aged 15-64 years; approximately 260 000 each year). The target population was all individuals (aged 15-64 years) treated for OUD in the study period (n = 220 665). The outcome measure was fatal opioid-related poisoning (opioid death). The opioid death rate [per 100 person-years (PY)] and mortality rate ratios (MRR) were computed for study year, age group (15-24, 25-34, 35-64 years) and for three treatment-related states: time spent 'prior to treatment', 'during treatment' and 'after treatment'. RESULTS: Between April 2008 and March 2011, there were 3731 opioid deaths in the study: 741 during treatment (0.20 per 100 PY; referent category); 2722 prior to treatment [0.77 per 100 PY; MRR = 3.76, 95% confidence interval (CI) = 3.18-4.44]; and 268 after treatment (0.41 per 100 PY; MRR = 1.99, 95% CI = 1.64-2.41). By counterfactual estimation, national OUD treatment services prevented an average of 880 opioid deaths each year (95% CI = 702-1084). CONCLUSIONS: Between April 2008 and March 2011, a counterfactual model shows that the English public treatment system for opioid use disorder prevented an average of 880 deaths each year from opioid-related poisoning. Counterfactual models of mortality prevention can be used for outcome and performance monitoring of substance use disorder treatment systems.
AIM: A counterfactual model was used to estimate the number of fatal opioid-related poisonings prevented by public treatment services for opioid use disorder (OUD) in England between April 2008 and March 2011. METHODS: Patient OUD treatment episode data recorded by the English National Drug Treatment Monitoring System were linked to data on opioid deaths recorded by the Office for National Statistics. The source population was the official estimate of non-medical opioid users (aged 15-64 years; approximately 260 000 each year). The target population was all individuals (aged 15-64 years) treated for OUD in the study period (n = 220 665). The outcome measure was fatal opioid-related poisoning (opioid death). The opioid death rate [per 100 person-years (PY)] and mortality rate ratios (MRR) were computed for study year, age group (15-24, 25-34, 35-64 years) and for three treatment-related states: time spent 'prior to treatment', 'during treatment' and 'after treatment'. RESULTS: Between April 2008 and March 2011, there were 3731 opioid deaths in the study: 741 during treatment (0.20 per 100 PY; referent category); 2722 prior to treatment [0.77 per 100 PY; MRR = 3.76, 95% confidence interval (CI) = 3.18-4.44]; and 268 after treatment (0.41 per 100 PY; MRR = 1.99, 95% CI = 1.64-2.41). By counterfactual estimation, national OUD treatment services prevented an average of 880 opioid deaths each year (95% CI = 702-1084). CONCLUSIONS: Between April 2008 and March 2011, a counterfactual model shows that the English public treatment system for opioid use disorder prevented an average of 880 deaths each year from opioid-related poisoning. Counterfactual models of mortality prevention can be used for outcome and performance monitoring of substance use disorder treatment systems.
Authors: Matthew Hickman; Colin Steer; Kate Tilling; Aaron G Lim; John Marsden; Tim Millar; John Strang; Maggie Telfer; Peter Vickerman; John Macleod Journal: Addiction Date: 2018-04-19 Impact factor: 6.526
Authors: John Marsden; Mike Kelleher; Eilish Gilvarry; Luke Mitcheson; Zoë Hoare; Dyfrig Hughes; Jatinder Bisla; Angela Cape; Fiona Cowden; Edward Day; Jonathan Dewhurst; Rachel Evans; Andrea Hearn; Joanna Kelly; Natalie Lowry; Martin McCusker; Caroline Murphy; Robert Murray; Tracey Myton; Sophie Quarshie; Gemma Scott; Sophie Turner; Rob Vanderwaal; April Wareham Journal: Trials Date: 2022-08-19 Impact factor: 2.728
Authors: Lu Gao; Polyxeni Dimitropoulou; J Roy Robertson; Stuart McTaggart; Marion Bennie; Sheila M Bird Journal: Drug Alcohol Depend Date: 2016-08-29 Impact factor: 4.492
Authors: Matthias Pierce; Sheila M Bird; Matthew Hickman; John Marsden; Graham Dunn; Andrew Jones; Tim Millar Journal: Addiction Date: 2015-11-25 Impact factor: 6.526
Authors: Brian Eastwood; Colin Drummond; Emmert Roberts; James C Doidge; Katie L Harron; Matthew Hotopf; Jonathan Knight; Martin White Journal: BMJ Open Date: 2020-11-26 Impact factor: 2.692